# A SHR-1210 BE Study on Healthy Subjects

> **NCT05799183** · PHASE1 · TERMINATED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** SHR-1210
- **DRUG:** SHR-1210

## Key facts

- **NCT ID:** NCT05799183
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-04
- **Primary completion:** 2023-10-12
- **Final completion:** 2023-10-12
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Sponsor's R\&D Strategy adjusted
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05799183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05799183, "A SHR-1210 BE Study on Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05799183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*